MobileODT Recognized for Imaging Technology Innovation in 2022 MedTech Breakthrough Awards Program
Prestigious Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies
Israeli FemTech Company MobileODT, Engaged in Large Scale Government Cervical Cancer Screening Project.
Israeli Digital Health FemTech company that is producing the latest innovation in cervical cancer screening
FemTech Company MobileODT awarded prestigious National Cancer Institute (NCI) SBIR grant of $2.3 million
FemTech company producing the latest digital innovation in cervical screening
MobileODT completed $4 million series round C
The round will support the development of AI cervical cancer screening device MobileODT, the developer of the EVA System for cervical cancer screening, announced the completion of a $4 million series C fundraising round. The round will enable MobileODT to further...
MobileODT completes second institutional financing
MobileODT is pleased to announce it has successfully completed its second round of institutional financing. The announcement comes shortly before the launch of its AI-based cervical cancer screening test, VisualPap. OrbiMed Israel Advisors led the round, with Tara...
MobileODT Receives Innovative Technology Contract from Vizient for the EVA System
MobileODT announces its EVA (Enhanced Visual Assessment) System has received an Innovative Technology contract from Vizient, Inc
Women’s Health Advocate Cherissa Jackson Joins MobileODT as Expert Advisor
June 25, 2019 TEL AVIV, Israel--MobileODT announced today that Cherissa Jackson will join its team as an expert advisor. A longtime champion in the fight against cervical cancer, Cherissa Jackson is a passionate author and motivational speaker, retired Air Force...
MobileODT launches EVA WELL for general gynecology in the USA
Tel Aviv, May 3, 2019: EVA WELL, the latest brand in MobileODT’s range of women’s health visualization solutions, was launched today at the American College of Obstetricians and Gynecologists (ACOG) annual conference in Nashville, TN. Designed for general gynecology,...
MobileODT’s CDS algorithm shows impressive results in first real-time application of AVE for cervical cancer screening
The first prospective pilot into artificial intelligence for point-of-care visual cervical cancer detection
The EVA System Colposcope fulfills the promise of the AVE algorithm to change future of cervical cancer detection
MobileODT, first to develop a commercial application for AVE machine learning algorithm for cervical cancer detection January 11, 2019 - Tel Aviv - A new augmented intelligence (AI) algorithm is able to detect cervical cancer based on a single image. Automated Visual...
MobileODT and partners to launch first wide-scale deployment of AI screening for Cervical Cancer
Chennai, India - January 7, 2019 - MobileODT, developer of the Enhanced Visual Assessment (EVA) System, will partner with Genworks and Apollo Hospitals to deliver its FDA-cleared smart mobile colposcope. The project will perform the first large-scale pilot of...
GE & MobileODT join forces to deploy the EVA System for early detection cervical cancer pilot study in Kenya
Kisumu County, Kenya - The EVA System mobile colposcope will be utilized for a new pilot study in Kenya to address Kisumu county's cervical cancer burden. Kenya faces approximately 4,800 new cervical cancer cases and 2,451 deaths annually. The Kisumu County Department...
MobileODT introduces advanced EVA 3 Plus mobile colposcope
The most powerful EVA colposcope yet, with even better imaging capabilities April 17th, 2018, Tel Aviv-- MobileODT will be launching its advanced EVA 3 Plus mobile colposcope, a key component of the EVA System for cervical cancer screenings and sexual assault...
MobileODT Technology Improves Cervical Cancer Detection Rates – Study in India
Cervical cancer contributes to approximately 6-29% of all cancers in Indian women. India accounts for one-quarter of cervical cancer globally. 17% of all cancer deaths amongst women in India aged 30-69 are due to cervical cancer. EVA System visualization technology...
MobileODT announces completion of Intel’s Kaggle competition to bring AI to cervical cancer screening
(August 2, 2017) Today, MobileODT announced the completion of the Intel & MobileODT Cervical Cancer Screening Kaggle Competition to develop a winning algorithm that will be used with the EVA (Enhanced Visual Assessment) System. The competition brought together...
Media Contact: media@mobileodt.com